
Diabetes is a very complicated disease to self-manage, and many people's understanding of critical aspects are over-simplified, incomplete, or just plain wrong. These articles aim to clarify the most common among these.
| Platform | Pricing | Only free issues | Publishes | Weekly | |
|---|---|---|---|---|---|
| Issues | 70 | Founded | 3 years ago | Last Issue | 5 days ago |
| Active | |||||

In case you haven’t noticed, there are some strange things going on regarding the 2026 ADA guidelines on heart disease management — particularly the part regarding LDL (low density lipoproteins). It may not be obvious at first, so let’s see...
Your CGM says 200, and you want to take a correction bolus. How many units do you pick?
Some would just shrug it off and offload it to something smarter, like a dosing calculator (if you’re on multiple daily injections — or, MDI), or the a...
Diabetic ketoacidosis — or DKA — is horrific, ranking as one of the most dangerous and painful acute complications of T1D. A Rutgers study published in Diabetes, Obesity and Metabolism found that, between 2002 and 2019, 42.0% to 44.8% of ch...
You find yourself at the mall, and your sugar is crashing. So you go to one of those kiosks that sells sugary junk food and buy a donut. You wolf it down. Then someone you know says, “Hey — can you really eat that?”
And you say, “Oh, you h...
We all know the drill. Before your next appointment you get an A1c test showing your average glucose over the last ninety days. Your doctor looks at it and says some version of: “Let’s see how we can get that lower.”
Naturally, as we all k...
Subscribers, engagement, traffic and sponsorship for Type 1 Diabetes: It's Not that Simple.
| Subscribers | Engagement | 74 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
The writers behind this newsletter.
Long time tech and biotech entrepreneur. Interested in type 1 diabetes and all things medicine
You can find recent issues that have been published by Type 1 Diabetes: It's Not that Simple on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
To see how many people subscribe to Type 1 Diabetes: It's Not that Simple, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
Newsletter advertising can be extremely effective when it's done right. Before you pitch Type 1 Diabetes: It's Not that Simple as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Type 1 Diabetes: It's Not that Simple using the contact information provided and ask for a copy of their media kit.
Scroll up to where it says Related Newsletters to see other publications like Type 1 Diabetes: It's Not that Simple. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.